Preformulation of a liquid dosage formulation of captopril for pediatric use: drug-excipient compatibility and stability studies

Currently, medications used in children are typically modified from pharmaceutical dosage forms designed for adults. Captopril is widely adapted to liquid formulations for use in hospitals. Its stability in the aqueous medium is reduced since it undergoes oxidation producing captopril disulfide (its main metabolite). The aim of this formulation study was to suggest favorable conditions for the development of a stable captopril formulation. The compatibility between the drug and excipients was evaluated by differential scanning calorimetry analysis (DSC). For studies in solution, different formulations were prepared according to a factorial design varying EDTA concentration, water purity and pH. The resultant formulations were stored at 60°C and analyzed over a twelve-day period using HPLC. The DSC curves obtained suggested, although not conclusive to elucidation, interactions of captopril with citric acid and sucralose. The stability study of these solutions revealed that the variables significantly influenced captopril content, which degraded at zero order kinetics and rates differing by a factor of up to 7 times, where pH proved the most influential factor. Interactions between variables were observed. Therefore, development of a stable captopril formulation is feasible provided EDTA and a buffering agent is used at suitable concentrations (0.08% and pH 3.85).

[1]  Amanda Natalina de Faria.  Princípios Físico-Químicos em Farmácia , 2019 .

[2]  S. Savić,et al.  A full factorial design in the formulation of diazepam parenteral nanoemulsions: Physicochemical characterization and stability evaluation , 2015 .

[3]  Pharmaceutical Press,et al.  Handbook of Pharmaceutical Excipients , 2012 .

[4]  M. Oliveira,et al.  Análise térmica aplicada a fármacos e formulações farmacêuticas na indústria farmacêutica , 2011 .

[5]  Steven Edward Kern,et al.  The Need for Modeling and Simulation to Design Clinical Investigations in Children , 2010, Journal of clinical pharmacology.

[6]  A. Awaisu,et al.  Dosing information in a standard drug reference: Are pediatrics still therapeutically neglected? , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[7]  J. Brustugun,et al.  Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  C. Tuleu,et al.  Meeting commentary--formulating better medicines for children. , 2009, International journal of pharmaceutics.

[9]  C. Aragão,et al.  Compatibility study between chlorpropamide and excipients in their physical mixtures , 2009 .

[10]  P. Costa,et al.  Carência de preparações medicamentosas para uso em crianças no Brasil , 2009 .

[11]  L. Rey,et al.  Lack of drug preparations for use in children in Brazil. , 2009, Jornal de pediatria.

[12]  P. Costa,et al.  Prescrição e preparo de medicamentos sem formulação adequada para crianças: um estudo de base hospitalar , 2009 .

[13]  J. Flynn.  Hypertension in the young: epidemiology, sequelae and therapy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  J. Brustugun,et al.  Influence of formulation properties on chemical stability of captopril in aqueous preparations. , 2008, Die Pharmazie.

[15]  M. Bonati,et al.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil , 2008, European Journal of Clinical Pharmacology.

[16]  H. J. Olguín,et al.  Frequency of drug consumption and lack of pediatric formulations , 2008 .

[17]  B. Testa,et al.  The development of a stable oral solution of captopril for paediatric patients , 2007 .

[18]  V. Pokharkar,et al.  Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. , 2006, International journal of pharmaceutics.

[19]  C. Tuleu,et al.  Paediatric formulations--getting to the heart of the problem. , 2005, International journal of pharmaceutics.

[20]  K. Rose.  Better medicines for children--where are we now, and where do we want to be? , 2005, British journal of clinical pharmacology.

[21]  M. J. García,et al.  Estudio de estabilidad de soluciones acuosas de captopril en concentración de 1 mg/ml , 2005 .

[22]  A. P. Marcatto,et al.  Analise de cápsulas de captopril manipuladas em farmacias , 2005 .

[23]  M. J. Escribano García,et al.  [Stability study of an aqueous formulation of captopril at 1 mg/ml]. , 2005, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

[24]  C. G. Carvalho,et al.  Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátrica , 2003 .

[25]  C. M. Salgado,et al.  Hipertensão arterial na infância , 2003 .

[26]  B. Horta,et al.  [Infantile colic incidence and associated risk factors: a cohort study]. , 2003, Jornal de pediatria.

[27]  M. Pedreira,et al.  Órfãos de terapia medicamentosa: a administração de medicamentos por via intravenosa em crianças hospitalizadas , 2003 .

[28]  N. Curi,et al.  Efeito da força iônica da solução de equilíbrio sobre a adsorção/dessorção de chumbo em Latossolos brasileiros , 2001 .

[29]  J. Schlatter,et al.  Stabilité d’une solution orale de captopril 1 mg/ml , 1997 .

[30]  P. Timmins,et al.  Factors affecting captopril stability in aqueous solution , 1982 .